Fintel reports that on August 18, 2023, UBS maintained its coverage of Privia Health Group (NASDAQ:PRVA). buy recommendation.
Analyst Price Expectations Suggest 55.37% Gains
As of August 2, 2023, Privia Health Group has an average one-year price target of $39.06. Expectations range from lows of $30.30 to highs of $47.25. The average target price is up 55.37% from the last reported closing price of 25.14.
See our leaderboard for companies with the highest price target increases.
Privia Health Group’s annual revenue is expected to grow 84.68% to 2,783 million. Projected full-year non-GAAP EPS is 0.02.
What is Fund Sentiment?
Privia Health Group has 477 funds or institutions reporting positions. This is an increase of 60 owners or 14.39% from the previous quarter.Portfolio average weight out of all funds PRVA dedicated was 0.19%, an increase of 14.32%. Total shares owned by institutional investors increased by 18.45% over the last three months to 110,363,000 shares. The PRVA put/call ratio is 0.34, indicating a bullish outlook.
What are other shareholders doing?
Durable Capital Partners owns 9,091,000 shares representing a 7.75% ownership interest in the company.
T. Rowe Price Investment Management owns 4,728,000 shares representing 4.03% of the company. Earlier filings reported that the company owned 2,771,000 shares. will increase 41.39%.office increased Portfolio allocation to PRVA increased 53.29% QoQ.
Wellington Management Group Llp holds 4,611,000 shares representing 3.93% of the company’s ownership. Earlier filings reported that the company owned 0,000 shares. will increase 100.00%.
Riverbridge Partners owns 4,344,000 shares representing a 3.70% ownership interest in the company. Earlier filings reported that the company owned 2,259,000 shares. will increase 47.99%.office increased Portfolio allocation to PRVA increased 63.52% QoQ.
Bank of New York Mellon owns 3,977,000 shares representing 3.39% of the company’s ownership. Earlier filings reported that the company owned 3,569,000 shares. will increase 10.28%.office Diminished Portfolio allocation to PRVA increased by 88.89% QoQ.
Background Information for Privia Health Group
(This description was provided by us.)
Privia Health™ works with health groups, health plans and health systems to optimize physician operations, improve patient experience, and reward physicians for providing high-value care, both in person and virtually. A national technology-driven physician assistance company. setting. Led by the leadership of industry-leading talent and outstanding physicians, the iTS Platform is a scalable operational and end-to-end platform that reduces unnecessary healthcare costs, achieves better outcomes, and improves patient health and well-being. It consists of two-end cloud-based technology. of the provider.
Fintel is one of the most comprehensive investment research platforms available to individual investors, traders, financial advisors and small hedge funds.
Our data covers the globe and includes fundamentals, analyst reports, ownership data and fund sentiment, option sentiment, insider trading, option flows, rare option trades and more. Additionally, our exclusive stock selection leverages advanced, back-tested quantitative models to improve profits.
Click to see details
This article was originally published on Fintel.
The views and opinions expressed herein are those of the authors and do not necessarily reflect those of Nasdaq, Inc.